Exporter

EN
FR
Codes ATC: L01XA02
Indication
Other specified malignant neoplasms of bronchus or lung Code ICD11: 2C75.Y
INN
Carboplatin
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
Formulations
Parenteral > General injections > IV: 50 mg per 5 mL ; 150 mg per 15 mL ; 450 mg per 45 mL ; 600 mg per 60 mL
Historique des statuts LME
Ajouté pour la première fois en 2009 (TRS 958)
Modifié en 2015 (TRS 994)
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite sur les brevets.
Balises
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Carboplatin was originally added to the complementary list of the EML in 2009 as a treatment of advanced ovarian cancer. In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for carboplatin on the complementary list of the EML for use in treatment protocols for non-small cell lung cancer was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for non-small cell lung cancer is attached.